Apr 11 2015 Published by drugmonkey under Fixing the NIH, NIH Careerism
I have decided to deploy a brand new Stock Criticism.
"No effort for a staff scientist is described, which may limit progress."
Feel free to borrow it.
5 responses so far
The part of Staff Scientist will be played by PI.
I like to go with "PI's exhausting list of invited talks and advisory panels obviously precludes responsible administration of the funds"
I think for R01s, you should put it in. For limiting the sustainability of the lab and project not for progress though.
[…] A new Stock Criticism for NIH Grants Private Eyes in the Grocery Aisles Why do we have allergies? (I’ve kind of suspected this hypothesis, since I get ‘allergy-like symptoms’ in really dry, dusty places) How I Discovered 30 New Species of Flies in Los Angeles Anti-vaxx mom abandons movement — after all seven her of her kids get whooping cough […]
DrugMonkey is an NIH-funded researcher who blogs about careerism in science. And occasionally about the science of drug use.
Site Admin | Theme by Niyaz
Drugmonkey Copyright © 2017 All Rights Reserved